drugset / Trial / NCT02671825

A PK Study to Evaluate PUR0200 and a Reference Product in Healthy Subjects

NCT02671825 ↗

Phase 1 Completed 42 enrolled Pulmatrix Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare drug blood levels of multiple formulations of inhaled PUR0200 to each other and to the reference product with and without oral charcoal.

Timeline

Start
2016-01
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject PUR0200 Unknown — Inhaled

Indications

No indication recorded.